Glipizide Er Tablets Suppliers & Bulk Manufacturers
Available Forms: ER Tablets
Available Strengths: 2.5 mg, 5 mg, 10 mg
Reference Brands: Glucotrol XL(US)
Category:
Diabetes
Glipizide ER tablets stimulate insulin release from pancreatic beta cells by blocking ATP-sensitive potassium channels, enhancing postprandial and basal glucose control. The extended-release formulation offers steady drug levels, reduced dosing frequency, and minimized peaks, helping lower the risk of hypoglycemia while effectively managing type 2 diabetes. Ideal for once-daily use.
Glipizide ER Tablets is available in ER Tablets
and strengths such as 2.5 mg, 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Glipizide ER Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Glipizide ER Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Glipizide ER tablets are FDA-approved in the USA for managing type 2 diabetes mellitus, helping patients achieve improved glycemic control. Marketed under brands like Glucotrol XL, the ER formulation allows once-daily dosing with steady plasma levels. In the European Union, availability varies by country, and while not as widespread, glipizide ER is recognized under specific regulatory pathways. EU regulators emphasize cardiovascular safety and monitoring of hypoglycemia risk. Manufacturers must comply with pharmacovigilance, GMP, and labeling standards. For B2B bulk sourcing, compliant and vetted suppliers can be accessed through platforms like Pharmatradz.com, supporting global regulatory demands.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing